CATALENT PHARMA SOLUTIONS INC SR GLBL 144A 30's ticker is and the CUSIP is 14879EAK4. A total of 1 filers reported holding CATALENT PHARMA SOLUTIONS INC SR GLBL 144A 30 in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $68,910 | -29.1% | 72,000 | -29.4% | 0.00% | – |
| Q1 2024 | $97,159 | -27.2% | 102,000 | -32.9% | 0.00% | – |
| Q4 2023 | $133,399 | +6.7% | 152,000 | 0.0% | 0.00% | – |
| Q3 2023 | $124,975 | +1.5% | 152,000 | 0.0% | 0.00% | – |
| Q2 2023 | $123,120 | -13.9% | 152,000 | -13.1% | 0.00% | -100.0% |
| Q2 2022 | $143,000 | -71.6% | 175,000 | -68.2% | 0.00% | -75.0% |
| Q1 2022 | $503,000 | – | 550,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pacer Advisors, Inc. | 152,000 | $123,120 | 0.00% |